Japan Animal Referral Medical Center Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Profit Before Tax
1,142.00
720.00
491.00
533.00
423.00
411.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-17.00
232.00
168.00
-46.00
-5.00
12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,395.00
1,372.00
899.00
810.00
557.00
504.00
Cash Flow from Investing Activities
-2,486.00
-994.00
-985.00
-784.00
-1,425.00
-69.00
Cash Flow from Financing Activities
1,575.00
-608.00
-392.00
820.00
722.00
-469.00
Net Cash Inflow / Outflow
485.00
-230.00
-478.00
847.00
-146.00
-34.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Japan Animal Referral Medical Center Co., Ltd.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
1142.017
807
335.00
41.51%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-17.761
-360
343.00
95.07%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1395.827
1154
241.00
20.96%
Cash Flow from Investing Activities
-2486.034
-1068
-1,418.00
-132.77%
Cash Flow from Financing Activities
1575.489
284
1,291.00
454.75%
Net Cash Inflow / Outflow
485.282
371
114.00
30.80%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 1.71% vs 52.52% in Mar 2025
Mar'26
Mar'25
Change(%)
Cash Flow from Operating Activities
1,395.83
1,372.38
1.71%






